United Orthopedic

United Orthopedic

4129 · TWO · Healthcare / Medical Devices

74.00TWD+1.30 (+1.79%)

Price History

Full chart

Market Stats

Previous Close72.70
Open72.70
Day Range72.60 – 74.00
52-Week Range81.00 – 125.05
Volume198.90K
Market Cap7.94B
P/E (TTM)14.78
Forward P/E68.49
EPS5.57
Dividend Yield5.47%
Beta0.41
50-Day Avg83.91
200-Day Avg97.06

About

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; spinal products comprising vertebral fixation devices; injury and other orthopedic products that consist of orthopedic internal fixation, bone plates, bone nails, bone pins, and bone screws and products; and OEM products, such as orthopedic internal fixation. It also provides its manufacturing equipment, as well as special metal and plastic materials. The company was incorporated in 1993 and is headquartered in New Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Deqiong Lin
  • Employees0
  • HeadquartersNo.80, Sec.1, Chenggong Rd., New Taipei City, Taiwan, 234634, Taiwan
  • Websitehttps://www.unitedorthopedic.com

Leadership

  • Mr. Deqiong LinVP & Director
  • Mr. Chien-Chong LiaoVice President
  • Lin TerchienPresident & Manager
  • Mr. Yuan-Chang DengDivisional Head of Department of Finance & Accounting and Accounting Supervisor
  • Chih Chieh ChengChief Information Security Officer

Financials

Income Statement

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.39B1.42B1.97B2.32B2.45B2.35B2.57B3.16B3.94B4.65B5.66B
Growth (%)-+1.62%+38.88%+17.94%+5.73%-4.23%+9.62%+22.88%+24.78%+17.95%+21.54%
Cost of Revenue406.73M496.77M642.08M862.31M903.23M901.17M940.64M1.04B1.18B1.03B1.26B
Gross Profit985.84M918.38M1.32B1.46B1.55B1.45B1.63B2.12B2.77B3.62B4.40B
Gross Margin70.79%64.90%67.33%62.80%63.14%61.60%63.44%67.12%70.13%77.85%77.79%
Operating Expense806.62M758.70M1.16B1.37B1.47B1.36B1.47B1.78B2.22B3.00B3.66B
Operating Income179.23M159.69M161.94M84.80M81.44M89.88M161.43M341.58M543.27M624.01M736.70M
Operating Margin12.87%11.28%8.24%3.66%3.32%3.83%6.27%10.80%13.77%13.41%13.03%
EBITDA-263.23M312.33M299.58M351.54M376.68M471.16M676.84M939.74M1.08B1.34B
EBITDA Margin-18.60%15.89%12.92%14.34%16.05%18.31%21.41%23.82%23.17%23.72%
Net Income133.81M146.60M130.26M127.55M88.58M101.83M52.27M221.53M384.20M456.43M562.50M
Net Income Margin9.61%10.36%6.63%5.50%3.61%4.34%2.03%7.01%9.74%9.81%9.95%
R&D151.65M161.23M198.73M200.45M188.34M155.09M143.68M167.26M185.03M220.49M262.54M
R&D as % of Total Revenue10.89%11.39%10.11%8.65%7.68%6.61%5.58%5.29%4.69%4.74%4.64%
Interest Expense05.58M13.24M26.80M33.38M31.39M17.64M24.11M44.14M43.19M45.95M
Interest Expense % of Total Revenue0.00%0.39%0.67%1.16%1.36%1.34%0.69%0.76%1.12%0.93%0.81%

Balance Sheet

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.59B2.96B4.30B4.85B5.24B5.59B5.24B5.62B6.42B7.04B7.82B
Total Liabilities820.18M1.15B2.08B2.60B2.31B2.66B2.42B2.53B2.82B3.09B3.62B
Total Equity1.77B1.77B2.20B2.23B2.83B2.82B2.72B2.99B3.50B3.85B4.10B
Cash731.44M477.93M401.39M528.48M539.12M838.93M638.68M398.06M449.02M610.68M662.81M
Total Debt-640.81M1.38B1.96B1.61B1.92B1.72B1.57B1.63B--
Net Debt-162.88M982.43M1.43B1.07B1.09B1.08B1.18B1.18B1.07B1.17B

Cash Flow

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow252.75M179.03M2.90M12.41M492.45M481.65M334.64M340.79M398.43M717.29M1.03B
Investing Cash Flow-199.23M-725.29M-1.11B-388.00M-522.59M-299.54M-186.72M-380.35M---
Financing Cash Flow434.11M263.82M1.04B466.76M-195.91M128.34M-307.79M-209.96M148.09M--
Capital Expenditure207.93M394.53M584.43M386.17M299.41M231.79M227.21M386.21M557.53M589.33M761.23M
Free Cash Flow--215.50M-581.53M-373.76M193.04M249.86M107.43M-45.42M-159.10M127.96M264.60M
Dividends Paid68.08M114.80M99.55M100.40M160.90M69.14M88.77M-200.61M385.87M385.87M
FCF to OCF--120.37%-20059.85%-3011.80%39.20%51.88%32.10%-13.33%-39.93%17.84%25.79%
Dividend Paid to FCF--53.27%-17.12%-26.86%83.35%27.67%82.63%--126.09%301.56%145.83%

Earnings

Report DateAug 12, 2014Nov 11, 2014Mar 24, 2015Apr 2, 2015Aug 12, 2015Nov 11, 2015Mar 30, 2016May 6, 2016Aug 4, 2016Nov 2, 2016Mar 19, 2017May 12, 2017Aug 14, 2017Nov 13, 2017Mar 28, 2018May 10, 2018Aug 13, 2018Nov 13, 2018May 10, 2019Aug 14, 2019Nov 13, 2019Mar 24, 2021Apr 28, 2021Aug 8, 2021Nov 9, 2021Mar 24, 2022May 16, 2022Aug 14, 2022Nov 9, 2022Mar 21, 2023May 14, 2023Aug 14, 2023Nov 14, 2023Mar 14, 2024May 15, 2024Aug 14, 2024Nov 12, 2024Mar 17, 2025May 7, 2025Aug 13, 2025Nov 12, 2025Mar 13, 2026Aug 14, 2026
EPS Estimate0.420.100.410.380.450.540.490.540.810.530.530.420.940.680.640.241.110.260.280.710.550.410.20---0.340.39-0.200.610.790.851.591.081.251.371.581.271.321.151.551.49
EPS Actual0.180.320.460.440.880.680.351.160.55-0.130.47-0.051.180.330.290.330.400.220.190.590.200.56-0.07-0.040.050.370.380.260.831.050.770.971.301.270.981.061.441.271.980.481.911.291.44
Surprise-57.14%220.00%12.20%15.79%95.56%25.93%-28.57%114.81%-32.10%-124.53%-11.32%-111.90%25.53%-51.47%-54.69%37.50%-63.96%-15.38%-32.14%-16.90%-63.64%36.59%-135.00%---11.76%-33.33%-425.00%26.23%22.78%52.94%-20.13%-9.26%-15.20%5.11%-19.62%55.91%-63.64%66.09%-16.77%-3.36%
TimingPre-marketAfter-hoursAfter-hoursPre-marketPre-market-After-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap7.94B
Enterprise Value9.78B
Trailing P/E14.78
Forward P/E68.49
Price / Sales1.31
Price / Book2.05
EPS5.57
Book Value40.47
Revenue (TTM)6.07B
Gross Profit (TTM)4.74B
EBITDA1.23B
Profit Margin9.09%
Operating Margin12.02%
Return on Equity14.28%
Return on Assets5.56%
Shares Outstanding96.44M
Shares Float77.38M
Beta0.41
Dividend Yield5.47%
Dividend Rate4.50
Payout Ratio96.98%

Dividends

20261×
4.50Jul 23, 2026
20251×
4.00Jul 23, 2025
20241×
4.00Jul 18, 2024
20231×
2.28Jul 24, 2023
20211×
0.84Sep 6, 2021
20201×
0.82Jul 27, 2020
20191×
2.00Jul 16, 2019
20181×
1.26Jul 10, 2018
20171×
1.36Jul 14, 2017
20161×
1.56Jul 11, 2016
20151×
1.14Jul 20, 2015
20141×
0.42Jul 29, 2014
20131×
0.38Aug 1, 2013
20121×
0.92Jul 19, 2012
20111×
0.62Jul 19, 2011
20101×
0.84Jul 27, 2010